Nunatak Capital

The firm invests exclusively in startups where data science forms the core of the product or competitive advantage. It is sector-agnostic, evaluating companies on the depth and defensibility of their data-science capabilities. This thesis extends from pre-seed to early growth stages, provided the startup can demonstrate product-market fit.

Nunatak Capital embeds its own data scientists and operators into portfolio companies to help build analytics infrastructure, optimize data pipelines, and strengthen the technical foundations of the product. The firm's founding team includes academic researchers and practitioners who contribute directly to the technical work of portfolio companies, rather than limiting support to board-level governance.

Nunatak Capital does not restrict itself to specific verticals. Its portfolio companies apply data science across enterprise AI, digital health, insurtech, industrial technology, and customer-service automation. The common thread is the centrality of data science to the product, not the end-market served.

Yes, Nunatak Capital has led rounds for its portfolio companies. Its disclosed led seed round for Quantee, an insurance pricing platform, amounted to $700k. The firm has also participated in later-stage growth rounds for companies developing AI solutions for customer service and medical diagnostics.

Nunatak Capital describes its team as a collective of scientists, managers, and entrepreneurs but has not publicly disclosed individual names, titles, or a formal investment committee structure. The firm operates as a unified investment entity without a publicly profiled CIO or managing partner.